NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
NCT05375812 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 85
Last updated 2026-05-22
Summary
Background:
Gulf War illness (GWI) affects up to 210,000 U.S. veterans who served in the Middle East during the Gulf War in 1990-1991. Symptoms include fatigue, muscle and joint pain, forgetfulness, headaches, rashes, and sleep disturbances. Routine exams cannot determine the cause of GWI. Researchers need more information to understand this disease.
Objective:
This natural history study will look for differences in Gulf War veterans who experienced GWI and those who did not.
Eligibility:
Gulf War veterans with GWI. Healthy Gulf War veterans who do not have GWI are also needed.
Design:
Participants will stay in the NIH Clinical Center as an inpatient for 2 weeks. They will undergo many tests.
Blood will be drawn many times throughout the study. Participants will also give urine, saliva, and stool samples.
Scans to measure the brain, leg muscles, bone density and body mass will be done.
They will have an exercise stress test and muscle strength tests.
They will have a sleep study. They will have tests to look at how well the brain, heart and lungs are working.
Participants will sleep in a specialized room that measures the amount of oxygen they use and the carbon dioxide they produce on four consecutive nights.
A sample of fluid will be collected from inside the spine.
Participants will take many surveys. Some will ask about their activities. Some will be about emotional and mental health. Some will be about thinking, memory, and behavior.
Optional tests include other imaging scans and testing the autonomic nervous system. Samples of skin and muscle may be taken.
After discharge, participants will wear activity monitors for 14 days. They will keep a diary of their symptoms, including fatigue, pain, and sleep, while wearing the monitors.
Conditions
- Gulf War Illness
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Brian T Walitt, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 48 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-16
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Vietnam Head Injury Study - Phase III
NCT00132249 ·Status: COMPLETED
-
Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging
NCT05101239 ·Status: ACTIVE_NOT_RECRUITING
-
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
NCT04124029 ·Status: RECRUITING
-
Deployment Related Mild Traumatic Brain Injury (mTBI)
NCT01847040 ·Status: COMPLETED
-
Measure of Cerebrovascular Dysfunction After TBI With fNIRS
NCT01789164 ·Status: COMPLETED
-
A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
NCT06682767 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The DIAGNOSE CTE Research Project-II
NCT06860828 ·Status: ENROLLING_BY_INVITATION
-
Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity
NCT04116229 ·Status: COMPLETED ·Phase: NA
-
Building Research for Intervention Development in Gliosis and Eating Habits
NCT06870578 ·Status: RECRUITING ·Phase: NA
-
Imaging Characterization of the Biomechanical Coupling of Brain and Skull
NCT05675423 ·Status: WITHDRAWN
-
Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes
NCT02957461 ·Status: COMPLETED
-
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
NCT01353196 ·Status: COMPLETED
-
Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members
NCT05183087 ·Status: COMPLETED
-
Dysregulated CNS Inflammation After Acute Brain Injury
NCT03287557 ·Status: COMPLETED
-
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
NCT03999164 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Early Detection of Mild Cognitive Impairment in Individual Patients
NCT00243451 ·Status: COMPLETED
-
Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI)
NCT01021137 ·Status: COMPLETED
-
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
NCT03265912 ·Status: COMPLETED
-
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
NCT01812213 ·Status: TERMINATED ·Phase: PHASE2
-
Definition, Quantification, and Utility of Biomarkers of Repetitive Brain Injury in Predicting Concussion and Other Long-Term Injury Risks in Patients With Atrial Fibrillation (Concussion AF)
NCT03875131 ·Status: COMPLETED
-
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )
NCT02686216 ·Status: COMPLETED ·Phase: PHASE1
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1
-
NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
NCT06453915 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
NCT05337774 ·Status: TERMINATED ·Phase: PHASE1
-
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease
NCT03130036 ·Status: COMPLETED ·Phase: NA